Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy

Shouichi Ohga, Mitsumasa Saito, Akinobu Matsukazi, Takeshi Kai, Kohji Ueda

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Summary. We report a case of haemophilia B, who developed disseminated intravascular coagulation (DIC) with massive bleeding following an administation of factor IX complex concentrates. A 22‐year‐old male with severe haemophilia B had a bone fracture of the fibula and haemorrhage in the ankle joint because of a traffic accident. Factor IX complex concentrates were given to keep the plasma factor IX level more than 80% for surgery. 60 h after the infusion he showed epistaxis, haematuria and swelling of the injured ankle with evidence of DIC. A small dose of monoclonal antibody (mAb)‐purified factor IX concentrates with heparin and gabexate relieved the haemorrhage. A high dose of the mAb‐purified product attained more than 90% levels of plasma factor IX without coagulopathy. This observation emphasizes that currently available factor IX concentrates have thrombogenicity to induce DIC. Highly purified factor IX concentrates are needed for the high‐dose replacement in haemophilia B.

Original languageEnglish
Pages (from-to)343-345
Number of pages3
JournalBritish Journal of Haematology
Volume84
Issue number2
DOIs
Publication statusPublished - Jun 1993

Fingerprint

Hemophilia B
Factor IX
Disseminated Intravascular Coagulation
Hemorrhage
Gabexate
Therapeutics
Fibula
Epistaxis
Ankle Joint
Traffic Accidents
Bone Fractures
Hematuria
Ankle
Heparin
Monoclonal Antibodies
3'-(1-butylphosphoryl)adenosine
prothrombin complex concentrates

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy. / Ohga, Shouichi; Saito, Mitsumasa; Matsukazi, Akinobu; Kai, Takeshi; Ueda, Kohji.

In: British Journal of Haematology, Vol. 84, No. 2, 06.1993, p. 343-345.

Research output: Contribution to journalArticle

Ohga, Shouichi ; Saito, Mitsumasa ; Matsukazi, Akinobu ; Kai, Takeshi ; Ueda, Kohji. / Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy. In: British Journal of Haematology. 1993 ; Vol. 84, No. 2. pp. 343-345.
@article{2e6caeec61504fc19764a7eb9744d924,
title = "Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy",
abstract = "Summary. We report a case of haemophilia B, who developed disseminated intravascular coagulation (DIC) with massive bleeding following an administation of factor IX complex concentrates. A 22‐year‐old male with severe haemophilia B had a bone fracture of the fibula and haemorrhage in the ankle joint because of a traffic accident. Factor IX complex concentrates were given to keep the plasma factor IX level more than 80{\%} for surgery. 60 h after the infusion he showed epistaxis, haematuria and swelling of the injured ankle with evidence of DIC. A small dose of monoclonal antibody (mAb)‐purified factor IX concentrates with heparin and gabexate relieved the haemorrhage. A high dose of the mAb‐purified product attained more than 90{\%} levels of plasma factor IX without coagulopathy. This observation emphasizes that currently available factor IX concentrates have thrombogenicity to induce DIC. Highly purified factor IX concentrates are needed for the high‐dose replacement in haemophilia B.",
author = "Shouichi Ohga and Mitsumasa Saito and Akinobu Matsukazi and Takeshi Kai and Kohji Ueda",
year = "1993",
month = "6",
doi = "10.1111/j.1365-2141.1993.tb03078.x",
language = "English",
volume = "84",
pages = "343--345",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy

AU - Ohga, Shouichi

AU - Saito, Mitsumasa

AU - Matsukazi, Akinobu

AU - Kai, Takeshi

AU - Ueda, Kohji

PY - 1993/6

Y1 - 1993/6

N2 - Summary. We report a case of haemophilia B, who developed disseminated intravascular coagulation (DIC) with massive bleeding following an administation of factor IX complex concentrates. A 22‐year‐old male with severe haemophilia B had a bone fracture of the fibula and haemorrhage in the ankle joint because of a traffic accident. Factor IX complex concentrates were given to keep the plasma factor IX level more than 80% for surgery. 60 h after the infusion he showed epistaxis, haematuria and swelling of the injured ankle with evidence of DIC. A small dose of monoclonal antibody (mAb)‐purified factor IX concentrates with heparin and gabexate relieved the haemorrhage. A high dose of the mAb‐purified product attained more than 90% levels of plasma factor IX without coagulopathy. This observation emphasizes that currently available factor IX concentrates have thrombogenicity to induce DIC. Highly purified factor IX concentrates are needed for the high‐dose replacement in haemophilia B.

AB - Summary. We report a case of haemophilia B, who developed disseminated intravascular coagulation (DIC) with massive bleeding following an administation of factor IX complex concentrates. A 22‐year‐old male with severe haemophilia B had a bone fracture of the fibula and haemorrhage in the ankle joint because of a traffic accident. Factor IX complex concentrates were given to keep the plasma factor IX level more than 80% for surgery. 60 h after the infusion he showed epistaxis, haematuria and swelling of the injured ankle with evidence of DIC. A small dose of monoclonal antibody (mAb)‐purified factor IX concentrates with heparin and gabexate relieved the haemorrhage. A high dose of the mAb‐purified product attained more than 90% levels of plasma factor IX without coagulopathy. This observation emphasizes that currently available factor IX concentrates have thrombogenicity to induce DIC. Highly purified factor IX concentrates are needed for the high‐dose replacement in haemophilia B.

UR - http://www.scopus.com/inward/record.url?scp=0027213354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027213354&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.1993.tb03078.x

DO - 10.1111/j.1365-2141.1993.tb03078.x

M3 - Article

C2 - 8398841

AN - SCOPUS:0027213354

VL - 84

SP - 343

EP - 345

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -